BHST - BioHarvest Sciences Inc Total Debt to Capital

Public company logo of BioHarvest Sciences (BHST)

A visual snapshot of price action on GURU.Markets demonstrates the 0.96 metric, while BioHarvest Sciences (BHST) develops advanced dietary supplements through a strategic alliance with nutraceutical manufacturers. The business relies on sustainable bioreactors that minimize water and land resource consumption. A unique B2B model for supplying plant-based cellular components for medicine ensures high returns and a stable cash flow.

BHST: BioHarvest Sciences Inc. Total Debt to Capital 11/13/2024 - 10/30/2026
Core merchandise of BioHarvest Sciences Inc

The implementation of robotic cell-growing platforms requires significant capital expenditures in bioreactor infrastructure for BioHarvest Sciences (BHST). The debt_total_eq_co ratio is calculated as the ratio of total liabilities to equity, determining the degree of financial leverage. This metric measures the business development's dependence on borrowed funds relative to internal resources. An optimal balance prevents bankruptcy risk while maintaining scaling momentum. The history of the company's leverage ratio clearly demonstrates the actual debt load on BioHarvest Sciences (BHST).

Competitor analysis for BioHarvest Sciences

Debt to Equity Haleon|Kenvue Inc - Aggregate Debt to Equity|Total Debt to Capital VRNA|MENS (Jyong Bio) - All Debt to Shareholders' Equity Ratio|Total Debt to Capital LGND (Ligand Pharmaceuticals)|Total Debt to Capital amneal.com AMRX|PRGO - Debt to Equity|All Debt to Shareholders' Equity Ratio ALVO (Alvotech S.A.)|Liquidia Technologies (LQDA) - Debt to Equity|Total Debt to Equity Ratio Galapagos Corp|ANIP (ANI Pharmaceuticals) - Total Debt to Capital|Total Debt to Capital mannkindcorp.com|Total Debt to Equity Ratio AMPH (Amphastar Pharmaceuticals, Inc.)|PCRX (Pacira Pharmaceuticals) - All Debt to Shareholders' Equity Ratio|Debt to Equity ARS Pharma SPRY|Theravance Corp (TBPH) - Debt to Capital|AQST: Total Debt to Equity Ratio|scPharmaceuticals Inc. - Aggregate Debt to Capital|TECX: Total Debt to Capital|Tonix Pharma - All Debt to Shareholders' Equity Ratio|SXTC (SXT Pharmaceuticals) - Total Debt to Capital|Debt to Capital Eupraxia Pharma EPRX|Debt to Equity eXoZymes Inc (EXOZ)|ORMP (oramed.com) - All Debt to Shareholders' Equity Ratio|Total Debt to Capital ENTX (Entera Bio)|MindWalk Holdings, Inc. - Debt to Equity|ABVC BioPharma Inc - Total Debt to Capital|Total Debt to Capital Coefficient Cumberland Corp CPIX|Quantum BioPharma Ltd (QNTM) - Debt to Equity|Debt to Capital fibrogen.com (FGEN)|TELO (Telomir Pharmaceuticals, Inc.) - Total Debt to Capital|RANI: All Debt to Shareholders' Equity Ratio|Total Debt to Capital SNYR|Total Debt to Capital rallybio.com (RLYB)|Debt to Equity Lexaria Bioscience Corp. LEXX|All Debt to Shareholders' Equity Ratio PULM|PTHL: Total Debt to Equity Ratio|APM: Debt to Equity|LYRA: Total Debt to Capital|Debt to Capital Impact BioMedical, Inc. (IBO)|Debt to Equity TNF Pharmaceuticals Inc.|cbdMD Corp (YCBD) - Total Debt to Capital Coefficient|Total Debt to Equity Ratio PRFX (PainReform)|Aggregate Debt to Capital CYTO|Lipella - Total Debt to Equity Ratio|All Debt to Shareholders' Equity Ratio OPTN|PIRS - Debt to Equity|Total Debt to Capital Coefficient procapsgroup.com PROC|PTPI: Total Debt to Capital|Total Debt to Equity Ratio Qilian International Holding Group|SLRN (ACELYRIN, Inc.) - Total Debt to Capital|TFF Pharmaceuticals, Inc (TFFP) - Total Debt to Capital Coefficient